Clinical Trials Browser

Phase 2 × Lung Neoplasms × Tadalafil × Clear all

NCT04069936 2022-08-02

Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis